For many people facing significant weight management challenges, medical weight loss can provide an effective, evidence-based approach. In recent years, GLP-1 receptor agonists and GIP/GLP-1 receptor agonists have become leading treatments, with medications such as Wegovy (semaglutide) and Mounjaro (tirzepatide) showing promising results.

Wegovy, a formulation of semaglutide, works by mimicking a natural hormone that regulates appetite. It helps reduce cravings and increase feelings of fullness. Clinical studies have shown that, when combined with a reduced-calorie diet and increased physical activity, Wegovy can support significant weight loss and improvements in overall health.

Mounjaro, with its active ingredient tirzepatide, offers a dual mechanism of action by targeting multiple pathways involved in glucose metabolism and appetite regulation. This innovative approach has also demonstrated impressive results, supporting substantial weight loss when used as part of a structured programme.

At Empower Weight Care, we emphasise that medication is just one part of the journey. Diet, mindset, and physical activity remain equally important. That’s why we carry out a full consultation before starting any treatment—to ensure safety, suitability, and alignment with your individual health needs and goals. Our role is to provide the knowledge, care, and guidance you need to make informed decisions with confidence.